Table 1.
Characteristic | Intervention group (n = 42) |
Control group (n = 40) |
P value |
---|---|---|---|
Male sex, n (%) | 41 (98) | 37 (93) | .35 |
Age, y, median | 64 | 63 | .65 |
Long-term care facility resident, | 7(17) | 8 (20) | .78 |
n (%) | |||
Medical condition, n (%) | |||
Diabetes | 19 (45) | 14(35) | .06 |
Cancer | 10(24) | 6(15) | .41 |
Chronic lung disease | 12(29) | 11 (28) | 1.0 |
Surgery in the past 3 mo | 13(31) | 8 (20) | .32 |
Colonized on admission, n (%) | |||
MRSA | 0(0) | 1 (2) | .49 |
VRE | 7(17) | 4(10) | .52 |
Fluoroquinolone-resistant | 6 (14) | 5(13) | 1.0 |
gram-negative bacilli | |||
Candida spp | 410) | 6(15) | .51 |
Proton pump inhibitor, n (%) | 26 (62) | 25 (51) | 1.0 |
Antibiotics within 90 d, n (%) | 22 (52) | 19(48) | .83 |
MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant enterococci.